Back
United Therapeutics Stock Price Chart
Sponsored
UTHR
Sponsored
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Buy
59
UTHR
United Therapeutics
Last Price:
376.96
Seasonality Move:
11.55%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing slight buying pressure.
United Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 360.88 | Buy |
20-day SMA: | 360.5 | Buy |
50-day SMA: | 355.15 | Buy |
200-day SMA: | 289.97 | Buy |
8-day EMA: | 366.26 | Buy |
20-day EMA: | 361.3 | Buy |
50-day EMA: | 352.78 | Buy |
200-day EMA: | 305.88 | Buy |
United Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.26 | Buy |
Relative Strength Index (14 RSI): | 65.01 | Buy |
Chaikin Money Flow: | 108847 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (350.76 - 367.98) | Buy |
Bollinger Bands (100): | (319.39 - 359.07) | Buy |
United Therapeutics Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for United Therapeutics Stock
Is United Therapeutics Stock a Buy?
- United Therapeutics share price is 376.80 while UTHR 8-day simple moving average is 360.88, which is a Buy signal.
- The stock price of UTHR is 376.80 while United Therapeutics 20-day SMA is 360.50, which makes it a Buy.
- United Therapeutics 50-day simple moving average is 355.15 while UTHR share price is 376.80, making it a Buy technically.
- UTHR stock price is 376.80 and United Therapeutics 200-day simple moving average is 289.97, creating a Buy signal.
UTHR Technical Analysis vs Fundamental Analysis
Buy
59
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics a Buy or a Sell?
-
United Therapeutics stock is rated a Buy
The current United Therapeutics [UTHR] share price is $376.80. The Score for UTHR is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
United Therapeutics Stock Info
Market Cap:
16.82B
Price in USD:
376.80
Share Volume:
321.83K
United Therapeutics 52-Week Range
52-Week High:
379.51
52-Week Low:
208.62
Buy
59
United Therapeutics (UTHR)
is a Buy
United Therapeutics Share Price Forecast
-
What is the United Therapeutics stock price today?
The United Therapeutics stock price is 376.80 USD today. -
Will UTHR stock go up or go down?
United Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is United Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics is not overvalued.
Is United Therapeutics Stock a Buy?
- United Therapeutics share price is 376.80 while UTHR 8-day exponential moving average is 366.26, which is a Buy signal.
- The stock price of UTHR is 376.80 while United Therapeutics 20-day EMA is 361.30, which makes it a Buy.
- United Therapeutics 50-day exponential moving average is 352.78 while UTHR share price is 376.80, making it a Buy technically.
- UTHR stock price is 376.80 and United Therapeutics 200-day simple moving average is 305.88, creating a Buy signal.
Fundamental Analysis of United Therapeutics
Is United Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.10 per share, and an increase next year of $2.37 per share.
Technical Analysis of United Therapeutics
Should I short United Therapeutics stock?
- UTHR Moving Average Covergence Divergence (MACD) indicator is 4.26, suggesting United Therapeutics is a Buy
- United Therapeutics Relative Strength Index (RSI) is 65.01, which suggest United Therapeutics is overbought
- The Bollinger Bands (25) for United Therapeutics is (350.76 - 367.98), which suggest United Therapeutics is a Buy
- The Bollinger Bands (100) for United Therapeutics is (319.39 - 359.07), which suggest United Therapeutics is a Buy
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.